Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Olaparib
Related studies linked through entity extraction aliases.
Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib in People With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Status
- RECRUITING
- Phase
- PHASE3
Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
- Status
- COMPLETED
- Phase
- PHASE2
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)
- Status
- COMPLETED
- Phase
- PHASE2
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
- Status
- COMPLETED
- Phase
- PHASE2
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes
- Status
- SUSPENDED
- Phase
- PHASE2
A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent
- Status
- TERMINATED
- Phase
- PHASE2
Olaparib In Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib
- Status
- COMPLETED
- Phase
- PHASE2
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Status
- RECRUITING
- Phase
- PHASE2